THE FORMER MOVIE MOGUL IS DUE BACK IN COURT NEXT WEEK.
BACK IN COURT NEXT WEEK.
>>> WITH THE DELTA VARIANT ON
THE RISE AND HOSPITALS AGAIN
FILLING WITH PATIENTS, SOME
TOP-LEVEL REPUBLICANS ARE STEPPING OUT TO URGE THAT
STEPPING OUT TO URGE THAT
HOLDOUTS GET VACCINATED.
>> Jason: AND THEY’RE DRIVING INFECTIONS FROM COAST TO COAST
INFECTIONS FROM COAST TO COAST
AND IS 99.5% OF COVID DEATHS.
THE U.S. HAS MORE THAN 1,000
EVERY HOUR.
AND THEY’RE PLEADING FOR FOLKS TO ROLL UP THEIR SLEEVES.
TO ROLL UP THEIR SLEEVES.
>> THESE SHOTS NEED TO GET IN
EVERYBODY’S ARM AS RAPIDLY AS
POSSIBLE.
>> IT’S SAFE AND EFFECTIVE AND I
TOOK IT AND I WANT TO ENCOURAGE PEOPLE.
>> Jason: THE NEW YORK CITY
MAYOR IS ENCOURAGING THOSE AT
CITY-RUN HOSPITALS TO GET
VACCINATED OR TAKE WEEKLY COVID TESTS.
SAN FRANCISCO IS MANDATING IT
FOR ALL CITY WORKERS
>>> THE INCREASING DOMINANCE OF
THE DELTA VARIANT HAS OFFICIAL CONCERNED AND A NEW STUDY IS
CONCERNED AND A NEW STUDY IS
RAISING QUESTIONS FOR THOSE WHO
RECEIVED THE JOHNSON & JOHNSON
VACCINE.
>> Kim: THE AMOUNT OF PROTECTION
IS NOT CLEAR.
DR. McGEORGE IS HERE TO EXPLAIN
THE NEWEST DEVELOPMENT. DOC?
>> Dr. McGeorge: IF YOU RECEIVED
THE PFIZER OR MODERNA MRNA
VACCINE, YOU’LL BE REASONABLY WELL PROTECTED.
WELL PROTECTED.
ONE STUDY FOUND AN 88% EFFICACY
AGAINST DELTA, ONLY MODEST
DECREASE OF ORIGINAL 95%. AND EXCELLENT PROTECTION AGAINST
AND EXCELLENT PROTECTION AGAINST
SEVERE DISEASE THAT WOULD
REQUIRE HOSPITALIZATION.
THE MOST CURRENT DATA FOR THE
JOHNSON & JOHNSON VACCINE IS NOT AS REASSURING.
AS REASSURING.
A NEW UNPUBLISHED STUDY LOOKED
AT THE NEUTRALIZING RESPONSE
AGAINST THE DELTA VARIANT IN
THOSE WHO RECEIVED THE JOHNSON &
JOHNSON VACCINE. THOSE ARE THE TYPE THAT ARE MOST
THOSE ARE THE TYPE THAT ARE MOST
EFFECTIVE IN STOPPING THE
INFECTION.
THE JOHNSON & JOHNSON VACCINE
WAS LESS EFFECTIVE AT PRODUCING THE NEUTRALIZING ANTIBODIES AND
THE NEUTRALIZING ANTIBODIES AND
BELIEVE IT COULD RESULT IN
DECREASED PROTECTION.
WHILE THIS ISN’T REASSURING,
IT’S BASED ON A BLOOD TEST THAT
ONLY MEASURES ONE PART OF A PERSON’S IMMUNE RESPONSE.
PERSON’S IMMUNE RESPONSE.
THE IMMUNE SYSTEM CAN PROTECT US
IN OTHER WAYS AND IT’S POSSIBLE
THAT STUDIES OF ACTUAL INFECTION
RATES IN PEOPLE MIGHT FIND A BETTER LEVEL OF PROTECTION OR
BETTER LEVEL OF PROTECTION OR
CONTINUED INFECTION AGAINST
SEVERE DISEASE.
AND PRIOR RESEARCH RELEASED BY
JOHNSON & JOHNSON FOUND THAT THE
VACCINE DID PRODUCE SIGNIFICANT NEUTRALIZING ANTIBODIES AND THAT
NEUTRALIZING ANTIBODIES AND THAT
THEY FURTHER INCREASED OVER
TIME.
OF COURSE, THE REAL ANSWER THAT PEOPLE WHO RECEIVED THE J & J
PEOPLE WHO RECEIVED THE J & J
SHOT JUST WANT TO KNOW, HOW WELL
ARE THEY PROTECTED?
AND BECAUSE THERE’S CONFLICTING DATA, I DON’T THINK WE CAN SAY.
DATA, I DON’T THINK WE CAN SAY.
ONE THING THAT THE AUTHORS DID
SUGGEST IS THAT A BOOSTER SHOOT
OR ONE OF THE MRNA VACCINES
MIGHT BE HELPFUL. >> Kim: AND ARE THERE STUDIES
>> Kim: AND ARE THERE STUDIES
THAT SAY A BOOSTER MIGHT
ACTUALLY HELP?
>> Dr. McGeorge: THERE’S SOME
INFORMATION LOOKING AT THE PEOPLE WHO RECEIVED THE J & J
PEOPLE WHO RECEIVED THE J & J
SHOT AND THEN HAD A SECOND ONE OR THE MRNA VACCINE AND BOTH
OR THE MRNA VACCINE AND BOTH
GROUPS SAW AN INCREASE IN
ANTIBODIES, BUT THERE NO RECOMMENDATIONS AT THIS POINT
RECOMMENDATIONS AT THIS POINT
AND THEY NEED MORE INFORMATION.
>> Jason: THE CDC HAS ANNOUNCED THE U.S. LIFE EXPECTANCY HAS
THE U.S. LIFE EXPECTANCY HAS
DROPPED BY ABOUT A YEAR AND A
HALF.
IT’S MAINLY DUE TO COVID-19.
PEOPLE BORN IN 2020 WILL LIVE
FOR A LITTLE MORE THAN 77 YEARS
ON AVERAGE. THE LIFE SPAN IS LOWER FOR MEN
THE LIFE SPAN IS LOWER FOR MEN
THAN IT IS FOR WOMEN.
MORE THAN 3.3 MILLION AMERICANS
DIED LAST YEAR, A RECORD IN U.S.
HISTORY. COVID WAS RESPONSIBLE FOR 11% OF